Weekly Versus Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer

John K. Chan, Mark F. Brady, Richard T. Penson, Helen Huang, Michael J. Birrer, Joan L. Walker, Paul A. Disilvestro, Stephen C. Rubin, Lainie P. Martin, Susan A. Davidson, Warner K. Huh, David M. O'Malley, Matthew P. Boente, Helen Michael, Bradley J. Monk

Research output: Contribution to journalComment/debate

Fingerprint Dive into the research topics of 'Weekly Versus Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer'. Together they form a unique fingerprint.